References
- Kohri N., Miyata N., Takahashi M., Endo H., Iseki K., Miyazaki K., Takechi S., Nomura A. Evaluation of pH‐independent sustained‐release granules of dipyridamole by using gastric‐acidity‐controlled rabbits and human subjects. Int. J. Pharm. 1992; 81(1)49–58
- Gabr K. E. Effect of organic acids on the release patterns of weakly basic drugs from inert sustained‐release matrix tablets. Eur. J. Pharm. Biopharm. 1992; 38(6)199–202
- Thoma K., Ziegler I. The pH‐independent release of fenoldopam from pellets with insoluble film coats. Eur. J. Pharm. Biopharm. 1998; 46(1)105–113, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Streubel A., Siepmann J., Dashevsky A., Bodmeier R. pH‐independent release of a weakly basic drug from water‐insoluble and ‐soluble matrix tablets. J. Control. Release 2000; 67(1)101–110, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Venkatesh H., Sanghavi N. M. Controlled drug delivery of pH‐dependent soluble drug, pindolol. Drug Dev. Ind. Pharm. 1994; 20(1)111–118
- Hegde D. D., Nagarsenker M. S., Garad S. D. Design and evaluation of extended release tablets of prochlorperazine maleate. Indian Drugs 2001; 38(2)69–74
- Takka S., Rajbhandari S., Sakr A. Effect of anionic polymers on the release of propranolol hydrochloride from matrix tablets. Eur. J. Pharm. Biopharm. 2001; 52(1)75–82, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Giunchedi P., Conte U., Maggi L., La Manna A. Hydrophilic matrixes for the extended release of a model drug exhibiting pH‐dependent solubility. Int. J. Pharm. 1992; 85(1–3)141–147, [CROSSREF]
- Dimitrov M., Lambov N. Study of verapamil hydrochloride release from compressed hydrophilic polyox‐Wsr tablets. Int. J. Pharm. 1999; 189: 105–111, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Goracinova K., Klisarova L. J., Simov A. Physical characterization and dissolution properties of verapamil. HCl coprecipitates. Drug Dev. Ind. Pharm. 1995; 21(3)383–391
- Goracinova K., Klisarova L. J., Simov A., Fredro‐Kumbaradzi E., Petrusevska‐Tozi L. Preparation, physical characterization, mechanisms of drug/polymer interactions, and stability studies of controlled‐release solid dispersion granules containing weak base as active substance. Drug Dev. Ind. Pharm. 1996; 22(3)255–262
- Nagarsenker M. S., Garad S. D. Physical characterization and optimization of dissolution parameters of prochlorperazine maleate coevaporates. Int. J. Pharm. 1998; 160(2)251–255, [CROSSREF]
- Nagarsenker M. S., Govindarajan R. Solid dispersion for extended release of verapamil‐HCl. Pharm. Pharmacol. Commun. 1998; 4(7)331–334
- Nagarsenker M. S., Garad S. D., Govindarajan R. Design, optimization and evaluation of domperidone coevaporates. J. Control. Release 2000; 63(1–2)31–39, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Chiou W. L., Riegelman S. Pharmaceutical applications of solid dispersion systems. J. Pharm. Sci. 1971; 60(9)1281–1302, [PUBMED], [INFOTRIEVE]
- United States Pharmacopoeia 23. United States Pharmacopoeial Convention Inc, Rockville, MD 1995; 2053
- Chang Z. L. Verapamil. Analytical Profiles of Drug substances, K. Florey. Academic Press, , California 1988; Vol. 17: 643–676
- Ritger P. L., Peppas N. A. A simple equation for description of solute release. I. Fickian and non‐Fickian release from non‐swellable devices in the form of slabs, spheres, cylinders or disks. J. Control. Release 1987; 5(1)23–36, [CROSSREF]
- Ritger P. L., Peppas N. A. A simple equation for description of solute release. II. Fickian and anomalous release from swellable devices. J. Control. Release 1987; 5(1)37–42, [CROSSREF]